Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1753-1758

  Marchand, Sandrine ^a,b,c   Lamarche, Isabelle ^a,b   Gobin, Patrice ^a,c   Couet, William ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ DE POITIERS   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Linearity; Nosocomial infections; Prodrug

Indexed keywords

COLISTIMETHATE; COLISTIN; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTERIAL BLOOD; ARTICLE; CONTROLLED STUDY; LIQUID CHROMATOGRAPHY; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT; TANDEM MASS SPECTROMETRY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMISTRY; INTRAVENOUS DRUG ADMINISTRATION; PLASMA; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, LIQUID; COLISTIN; INJECTIONS, INTRAVENOUS; MALE; PLASMA; RATS; RATS, SPRAGUE-DAWLEY; TANDEM MASS SPECTROMETRY;

EID: 77954754189     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq183     Document Type: Article

References (11)

1. Li J, Nation RL, Turnidge JD et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections. Lancet Infect Dis 2006; 6: 589-601.
2. Falagas ME, Rafailidis PI. Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives. Expert Opin Investig Drugs 2008; 17: 973-81.
3. Li J, Milne RW, Nation RL et al. Use of high-performance liquid chromatography to study the pharmacokinetics of colistin sulfate in rats following intravenous administration. Antimicrob Agents Chemother 2003; 47: 1766-70.
4. Jansson B, Karvanen M, Cars O et al. Quantitative analysis of colistin A and colistin B in plasma and culture medium using a simple precipitation step followed by LC/MS/MS. J Pharm Biomed Anal 2009; 49: 760-7.
5. Gobin P, Lemaître F, Marchand S et al. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography tandem mass spectrometry (LC-MS/MS). Antimicrobial Agents Chemother 2010; 54: 1941-8.
6. Plachouras D, Karvanen M, Friberg LE et al. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by Gram-negative bacteria. Antimicrob Agents Chemother 2009; 53:3430-6.
7. Marchand S, Dahyot C, Lamarche I et al. Microdialysis study of imipenem distribution in skeletal muscle and lung extracellular fluids of noninfected rats. Antimicrob Agents Chemother 2005; 49: 2356-61.
8. Li J, Milne RW, Nation RL et al. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate. J Antimicrob Chemother 2004; 53: 837-40.
9. Rowland M, Tozer TN. Clinical Pharmacokinetics: Concepts and Applications. Philadelphia: Lippincott Williams & Wilkins, 1995.
10. Derendorf H, Mollmann H, Rohdewald P et al. Kinetics of methylprednisolone and its hemisuccinate ester. Clin Pharmacol Ther 1985; 37: 502-7.
11. Dudhani RV, Turnidge JD, Coulthard K et al. Elucidation of pharmacokinetic/pharmacodynamic determinant of colistin activity against Pseudomonas aeruginosa in murine thigh and lung infection models. Antimicrob Agents Chemother 2010; 54: 1117-24.